The Deep Tech Angle: Investing in Translational Impact

What this is

A framework for evaluating deep tech without story-driven thinking. Deep tech here means science- or engineering-first ventures — advanced materials, semiconductors, novel manufacturing, platform biotech, climate hardware, sensing, infrastructure — where technical depth creates defensibility and timelines run longer than software.

The central claim: translation, meaning the move from lab proof to repeatable production, is the bottleneck where most projects die. Not the underlying science.

Four pressure tests

• Readiness: prototype, pilot, or repeatable production — and what the team means by repeatable.
• Unit economics: the real cost to make, ship, maintain and support, not a bill of materials priced at prototype volume.
• Validation path: the specific evidence that unlocks procurement, reimbursement, or a contract.
• Time horizon: runway-to-milestone planning, rather than an intention to raise later.

Capital structure is destiny

Good technology dies when dilution, runway and milestones are misaligned. The company runs out of road before it runs out of ideas.

Adoption is procurement-driven. Buyers pay for reliability, integration and risk reduction. They do not pay for novelty, whatever the pitch deck says about it.

Recurring failure modes

• Manufacturing scale and QC quietly becoming the actual product.
• Regulatory and compliance drag in healthcare and critical infrastructure.
• Partner dependency on a single customer, channel or grant.
• Demo success that never converts into stable operations.

Research brief. Informational only, and not investment, medical, legal, or tax advice. Verify any figure against the primary source before relying on it.

Written and reviewed by Pouyan Golshani, MD — April 2026